Monopar Therapeutics (MNPR) Cash & Equivalents (QoQ) (2017 - 2025)
Monopar Therapeutics (MNPR) Cash & Equivalents (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | Monopar Therapeutics | 817.59 Mn | 755.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -51.57% |
| Sep 30, 2025 | 223.22% |
| Jun 30, 2025 | -0.53% |
| Mar 31, 2025 | -13.32% |
| Dec 31, 2024 | 661.06% |
| Sep 30, 2024 | -1.63% |
| Jun 30, 2024 | -21.62% |
| Mar 31, 2024 | 7.45% |
| Dec 31, 2023 | 31.74% |
| Sep 30, 2023 | -23.55% |
| Jun 30, 2023 | -30.78% |
| Mar 31, 2023 | 27.33% |
| Dec 31, 2022 | -41.21% |
| Sep 30, 2022 | -15.42% |
| Jun 30, 2022 | -7.61% |
| Mar 31, 2022 | -10.97% |
| Dec 31, 2021 | -8.96% |
| Sep 30, 2021 | -9.51% |
| Jun 30, 2021 | -5.56% |
| Mar 31, 2021 | 54.91% |